Global Oncology Molecular Diagnostics Market 2015-2019

がん分子診断の世界市場:乳がん、大腸がん、前立腺がん

◆タイトル:Global Oncology Molecular Diagnostics Market 2015-2019
◆商品コード:IRTNTR6999
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2015年9月2日
◆ページ数:63
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Five UserUSD3,000 ⇒換算¥339,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、がん分子診断の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、がん分子診断の世界市場規模及び予測、市場シェア、がん種類別分析、地域別分析、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

・エグゼクティブサマリー
・市場概観
・業界の構造分析
・がん分子診断の世界市場:市場規模及び予測
・がん分子診断の世界市場:がん種類別分析
・がん分子診断の世界市場:地域別分析
・市場シェア
・市場の成長要因
・市場の課題
・市場動向
・競争状況
・主要企業(ベンダー)分析
...

※上記の和訳は最新内容ではない場合があります。下記の英文概要・目次が最新版です。

About oncology molecular diagnostics
Molecular diagnostics is one of the most transformative and dynamic areas of diagnostics. It is a technique used for analyzing biological markers in proteome and genome. Molecular diagnostics tests are increasingly used in oncology, infectious disease, pharmacogenomics, and human leukocyte antigen typing.

Oncology molecular diagnostics is a major application of molecular biology and is increasingly used for cancer screening, therapy selection, diagnosis, and relapse monitoring. Some of the major that are diagnosed and treated by molecular diagnostics are breast, ovarian, cervical, head and neck, pancreatic, colorectal, brain, prostate, lung, and endometrial cancers.

Technavio’s analysts forecast the global oncology molecular diagnostics market to grow at a CAGR of 17.8% over the period 2014-2019.

[Covered in this report]
The report covers the current scenario and the growth prospects of the global oncology molecular diagnostics market for the period of 2015-2019. To calculate the market size, the report considers revenue generated through the sales of diagnostics assay kits and instruments for cancers, which include:
• Breast
• Colorectal
• Prostate
• Others (including lung and cervical cancers)

Technavio’s report, Global Oncology Molecular Diagnostics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, Europe, Latin America, MEA, and North America; it also covers the landscape of the market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

[Key regions]
• APAC
• Europe
• Latin America
• MEA
• North America

[Key vendors]
• Abbott Diagnostics
• Becton, Dickinson and Company
• QIAGEN
• Roche Diagnostics

[Other prominent vendors]
• Agendia
• Angsana Molecular and Diagnostics
• Asuragen
• Autogenomics
• Beckman Coulter
• bioMérieux
• bioTheranostics (Formerly AviaraDx)
• Cangen Biotechnologies
• Cepheid
• Diagnocure
• Epigenomics
• Eragen
• EXACT Sciences
• Exiqon
• GeneNews
• Genera Biosystems
• Genomic Health
• Genomix Biotech
• Health Discovery
• HTG Molecular
• Hologic
• Innogenetics
• Intergenetics
• Kreatech Holding
• Myriad Genetics
• Nanosphere
• NorDiag
• Nuvera Biosciences
• OncoMethylome Sciences
• Orion Genomics
• Prediction Sciences
• Predictive Biosciences
• Rosetta Genomics
• SensiGen
• Source MDx
• Vermillion

[Market driver]
• Increase in demand for personalized medicines
• For a full, detailed list, view our report

[Market challenge]
• Ethical, privacy, and practical issues
• For a full, detailed list, view our report

[Market trend]
• Advances in mass spectrometry
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

【資料の目次】

PART 01: Executive summary
Highlights

PART 02: Scope of the report
Market overview
Top-vendor offerings

PART 03: Market research methodology
Research methodology
Economic indicators

PART 04: Introduction
Key market highlights

PART 05: Cancer statistics

PART 06: Market landscape
Market overview
Market size and forecast
Five forces analysis

PART 07: Reimbursement and coverage: An overview

PART 08: Molecular diagnostic products: Pricing scenario

PART 09: Market segmentation by cancer type
Breast cancer
Colorectal cancer
Prostate cancer
Other cancers

PART 10: Geographical segmentation
Oncology molecular diagnostics market in Americas
Oncology molecular diagnostics market in EMEA
Oncology molecular diagnostics market in APAC

PART 11: Market drivers

PART 12: Impact of drivers

PART 13: Market challenges

PART 14: Impact of drivers and challenges

PART 15: Market trends

PART 16: Vendor landscape
Competitive scenario
Market share analysis 2014
Other prominent vendors

PART 17: Key vendor analysis
Abbott Diagnostics
Becton, Dickinson
Qiagen

PART 18: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Snapshot of global oncology molecular diagnostics market 2015-2019
Exhibit 03: Prevalent cancers worldwide 2012
Exhibit 04: Countries with highest cancer rates 2012
Exhibit 05: Cancer by gender 2012
Exhibit 06: Global oncology molecular diagnostics market 2014-2019 ($ billions)
Exhibit 07: Five forces analysis
Exhibit 08: Reimbursement perspectives of healthcare entities
Exhibit 09: Factors influencing price of molecular diagnostic products
Exhibit 10: Global oncology molecular diagnostics market segmentation by cancer type
Exhibit 11: Global oncology molecular diagnostics market segmentation by cancer type 2014
Exhibit 12: Global oncology molecular diagnostics market by cancer type 2014 ($ millions)
Exhibit 13: Global oncology molecular diagnostics market segmentation by geography 2014
Exhibit 14: Global oncology molecular diagnostics market segmentation by geography 2019
Exhibit 15: Global oncology molecular diagnostics market by geography 2014-2019
Exhibit 16: Oncology molecular diagnostics market in Americas 2014-2019 ($ millions)
Exhibit 17: Oncology molecular diagnostics market in EMEA 2014-2019 ($ millions)
Exhibit 18: Oncology molecular diagnostics market in APAC 2014-2019 ($ millions)
Exhibit 19: Impact of drivers
Exhibit 20: Impact of drivers and challenges
Exhibit 21: Abbott: Key takeaways
Exhibit 22: Becton, Dickinson: Key takeaways
Exhibit 23: Qiagen: Key takeaways
Exhibit 24: Roche Diagnostics: Key takeaways
Exhibit 25: Abbott Diagnostics: Key business offerings
Exhibit 26: Becton, Dickinson: Business segmentation by revenue 2014
Exhibit 27: Becton, Dickinson: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 28: Becton, Dickinson: Geographical segmentation by revenue 2014
Exhibit 29: Segmentation of Qiagen’s business by revenues 2014



【掲載企業】

Abbott Diagnostics, Becton, Dickinson and Company, QIAGEN, Roche Diagnostics, Agendia, Angsana Molecular and Diagnostics, Asuragen, Autogenomics, Beckman Coulter, bioMérieux, bioTheranostics (Formerly AviaraDx), Cangen Biotechnologies, Cepheid, Diagnocure, Epigenomics, Eragen, EXACT Sciences, Exiqon, GeneNews, Genera Biosystems, Genomic Health, Genomix Biotech, Health Discovery, HTG Molecular, Hologic, Innogenetics, Intergenetics, Kreatech Holding, Myriad Genetics, Nanosphere, NorDiag, Nuvera Biosciences, OncoMethylome Sciences, Orion Genomics, Prediction Sciences, Predictive Biosciences, Rosetta Genomics, SensiGen, Source MDx ,Vermillion

【資料のキーワード】

がん分子診断、乳がん、大腸がん、前立腺がん、癌検査

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[がん分子診断の世界市場:乳がん、大腸がん、前立腺がん]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆